| Human |
hsa_circ_RAPGEF5 |
hsa_circ_0001681 |
- |
thyroid gland papillary carcinoma |
RAPGEF5 |
miR-198 |
Q
| UP |
More |
| Human |
hsa_circ_RAPGEF5 |
hsa_circ_0001681 |
- |
COVID-19 |
RAPGEF5 |
- |
Q
S
| DS |
More |
| Human |
- |
hsa_circ_0001681 |
- |
thyroid gland carcinoma |
- |
miR-942-5p |
Q
| UP |
More |
| Human |
- |
hsa_circ_0001681 |
circ_0001681 |
lung adenocarcinoma |
- |
miR-567 |
Q
M
| DN |
More |
| Human |
hsa_circ_RAPGEF5 |
hsa_circ_0001681 |
CircRAPGEF5 |
urinary bladder carcinoma |
RAPGEF5 |
miR-582-3p |
Q
| UP |
More |
| Human |
hsa_circ_RAPGEF5 |
hsa_circ_0001681 |
circ-RAPGEF5 |
colorectal cancer |
RAPGEF5 |
miR-545-5p |
Q
| UP |
More |
| Human |
hsa_circ_RAPGEF5 |
hsa_circ_0001681 |
- |
glioma |
RAPGEF5 |
hsa-miR-136 |
Q
S
| DN |
More |
| Human |
hsa_circ_RAPGEF5 |
hsa_circ_0001681 |
circRAPGEF5 |
lung adenocarcinoma |
RAPGEF5 |
miR-1236-3p |
Q
M
| UP |
More |
| Human |
hsa_circ_RAPGEF5 |
hsa_circ_0001681 |
circRAPGEF5 |
endometrial cancer |
RAPGEF5 |
- |
Q
S
| UP |
More |
| Human |
- |
hsa_circ_0001681 |
circ_0001681 |
urinary bladder carcinoma |
- |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_RAPGEF5 |
hsa_circ_0001681 |
circRAPGEF5 |
Alzheimer disease |
RAPGEF5 |
- |
Q
| DN |
More |
| Human |
hsa_circ_RAPGEF5 |
hsa_circ_0001681 |
Circ-RAPGEF5 / CircRAPGEF5 |
intrahepatic cholangiocarcinoma |
RAPGEF5 |
miR-3185 |
Q
S
| UP |
More |
| Human |
hsa_circ_RAPGEF5 |
hsa_circ_0001681 |
circRAPGEF5 / TC-hsa-RAPGEF5_0098 |
colorectal cancer |
RAPGEF5 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_RAPGEF5 |
hsa_circ_0001681 |
CircRNA RAPGEF5 / cRAPGEF5 |
renal cell carcinoma |
RAPGEF5 |
miR-27a-3p |
Q
| DN |
More |
| Human |
hsa_circ_RAPGEF5 |
hsa_circ_0001681 |
- |
colorectal cancer |
RAPGEF5 |
hsa-miR-664b-3p, hsa-miR-139-5p, hsa-miR-6509-5p, hsa-miR-323a-3p, hsa-miR-370-3p, hsa-miR-181a-5p, hsa-miR-181b-5p |
Q
S
| UP |
More |